Feilin Ge

First Affiliated Hospital of Zhengzhou University — China

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

9h-index246citations28works1.82yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug-Induced Hepatotoxicity and Protection(11), Hepatitis C virus research(9), Hepatitis B Virus Studies(9), Liver Disease Diagnosis and Treatment(9), Pharmacogenetics and Drug Metabolism(4)

Publications28 total

Study on the anti-liver cirrhosis of Fuzheng Huayu tablet : Targeting macrophage PPARα axis-fatty acid metabolic
Phytomedicine·2025
Age-related Gut Microbiome Profile and Reversal of Microbial Imbalance by Trimetazidine Intervention
2025Open Access
Pescadillo ribosomal biogenesis factor 1 as a therapeutic target in tumor immunotherapy
World Journal of Gastroenterology·2025Open Access
Inhibition of hepatitis B virus through PPAR-JAK/STAT pathway modulation by electroacupuncture and tenofovir disoproxil fumarate combination therapy
International Immunopharmacology·2024· 5 citedOpen Access
An Experimental Animal Study: Electroacupuncture Facilitates Antiviral Immunity Against Hepatitis B Virus Through the IFN-γ/JAK/STAT Axis
Journal of Inflammation Research·2024· 2 citedOpen Access
Inhibition of hepatitis B virus <i>via</i> selective apoptosis modulation by Chinese patent medicine Liuweiwuling Tablet
World Journal of Gastroenterology·2024· 5 citedOpen Access
PreS1BP mediates inhibition of Hepatitis B virus replication by promoting HBx protein degradation
Virus Research·2024· 2 citedOpen Access
Risk Stratification for Drug-Induced Liver Injury: A Regional Public Health Big Data Study in China
SSRN Electronic Journal·2024Open Access
The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges
Chinese Medicine·2023· 14 citedOpen Access
Identification the shared pathogenesis between chronic hepatitis B and non-alcoholic fatty liver disease: Evidence from transcriptome data
Gastroenterology & Endoscopy·2023Open Access
The efficacy and safety of Chinese patent medicine LWWL combined with nucleoside/nucleotide analogues in treatment of chronic hepatitis B: A systematic review and meta-analysis
Gastroenterology & Endoscopy·2023· 1 citedOpen Access
Data Mining-based Analysis of Acupoint Selection Patterns for Chronic Hepatitis B Infection
Gastroenterology and Hepatology Research·2023· 2 citedOpen Access
Glycyrrhiza uralensis polysaccharides ameliorate acute lung injury by inhibiting the activation of multiple inflammasomes
Journal of Functional Foods·2022· 20 citedOpen Access
A review of herb-induced liver injury in mainland china
Frontiers in Pharmacology·2022· 20 citedOpen Access
Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients
Disease Markers·2022· 8 citedOpen Access
Landscape of DILI-related adverse drug reaction in China Mainland
Acta Pharmaceutica Sinica B·2022· 39 citedOpen Access
Schisandra chinensis Oil Attenuates Aristolochic Acid I-Induced Nephrotoxicity in vivo and in vitro
Chinese Journal of Integrative Medicine·2022· 3 cited
Age-Associated Risk of Liver-Related Adverse Drug Reactions
Frontiers in Medicine·2022· 7 citedOpen Access
Randomized Controlled Trials of Zhigancao Decoction Combined With Metoprolol in the Treatment of Arrhythmia: A Systematic Review and Meta-Analysis
Frontiers in Cardiovascular Medicine·2022· 11 citedOpen Access
The efficacy and safety of Chinese patent medicine LWWL combined with nucleoside/nucleotide analogues in treatment of chronic hepatitis B: A systematic review and meta-analysis
2021Open Access
page 1 of 2Next →

Frequent Co-authors

Xiaohe Xiao(16), Zhaofang Bai(12), Ming Niu(7), Jiabo Wang(7), Yuming Guo(7), Haibo Song(6), Lanlan Si(6), Zixin Han(5), Yan Liu(5), Zhigang Ren(5), Yuanhua Li(4), Yan Yang(4), Peng Xiong(3), Jing Jing(3), Yanzhong Han(3), Yan Yang(3), Hao Liao(3), Jun Wang(3), Chenglin Tang(3), Yunhao Yang(3)